NOBEL Pharma Schweiz AG - Sitagliptin Metformin NOBEL 50 mg/850 mg, Filmtabletten | | 68967 | | 02 | | Sitagliptin Metformin NOBEL 50 mg/850 mg | | Filmtabletten | | A10BD07 | | Metformine et Sitagliptine | | 28.12.2023 | | |
| Composition | sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum 56.69 mg, metformini hydrochloridum 850 mg, povidonum K 30, cellulosum microcristallinum, crospovidonum, natrii stearylis fumaras corresp. natrium 1.301 mg, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto. | Packungsbestandteile | | Filmtabletten | | | Principe actif | Concentr. |
---|
Metformini Hydrochloridum | 850 mg | Sitagliptinum | 50 mg |
| BAG: Principe actif | Concentr. |
---|
Metformini Hydrochloridum | 850 mg | Sitagliptinum | 50 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Flavum) | | | (Nigrum) | | | (Rubrum) | | | Cellulosum Microcristallinum | | | Crospovidonum | | | E 171 | | color. | E 172 | | color. | Macrogolum | 3350 | | Natrii Stearylis Fumaras | | | Poly(Alcohol Vinylicus) | | Überzug | Povidonum K | 30 | | Pro Compresso Obducto | | | Talcum | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
003 | 56 | 9.50 | 26.75 | B | LS | Non | 004 | 4 x 49 | 33.27 | 52.60 | B | LS | Non |
|
|